Navigation Links
Stryker to Host Analyst Meeting
Date:1/30/2009

KALAMAZOO, Mich., Jan. 30 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that it will conduct an Analyst Meeting on Wednesday, May 20, 2009, at 8:00 a.m. Eastern Time, in New York, New York.

Stephen P. MacMillan, President and Chief Executive Officer, will host the meeting with presentations by leaders of the Company's key business units.

A simultaneous webcast of the meeting will be available on Stryker's website at www.stryker.com via the For Investors page. The webcast will be archived on this site for 90 days. To hear the meeting via telephone, dial 800-884-5695 (domestic) or 617-786-2960 (international) and enter registration number 98922638.

A recording of the meeting will be available from 12:00 p.m. Eastern Time, on May 20, 2009, until 12:00 p.m. Eastern Time, on May 27, 2009. To hear this recording, dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter registration number 20013937.

Certain statements made in the presentation may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: further weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; changes in foreign exchange markets; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approv
'/>"/>

SOURCE Stryker Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Stryker Operating Results for Quarter Ended December 31, 2008
2. LegalView Developing Cranial Implant Information Portal Detailing the Recall of Stryker Cranial Implant Kits
3. Stryker Updates Expected 2008 Results and Provides 2009 Outlook
4. Stryker To Present at Investor Conference
5. Stryker Increases Annual Dividend by Over 20%
6. Stryker Announces Organizational and Leadership Changes
7. Stryker to Present at Investor Conferences
8. Stryker To Present at Investor Conference
9. Stryker to Present at Investor Conferences
10. Stryker to Present at Investor Conference
11. Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...The Center for Science Writings at Stevens Institu...d," a talk by Robert Wright, journalist and founde...4:00-5:30 p.m. at the Babbio Center for Technology...to the public and the media., In his new book "T...obert Wright, renowned for his popular works on ev...
(Date:11/23/2009)...09 -- Exposure shortly after birth to ambient meta...ticles from diesel emissions are associated with r...according to a new study by researchers at the Col...CCCEH) at Columbia University,s Mailman School of ...the effects of exposure to airborne metals in this...
(Date:11/23/2009)...ome-based settings get far more screen time than ... , MONDAY, Nov. 23 (HealthDay News) --Young child...ion every day than previous reports have found, es...ew study finds. , Researchers from Seattle Chil...urveyed day-care directors to find out how much te...
(Date:11/23/2009)...LIS,Nov.23/PRNewswire/--ThousandsofpeoplewithiPhon...edtohelppeoplewithdiabetesbettermanagetheirdisease...ndwhattheycandotobettermanagetheirbloodsugar.Nowit...uddyavailablenow. ,, RocheDiabetesCare,themaker...ulindeliverysystems,haspartneredwithMYLEstoneHealt...
(Date:11/23/2009)...A,Va.,Nov.23/PRNewswire/--JustintimefortheThanksgi...efswithtipsandrecipesforcookingupadeliciousmeal:de...andhealthinformation, turkeyfrying.net alsopro...aswellaspartyideasfortakingtheturkeybeyondThanksgi...lySouthernwayofdeep-fryingwith100%peanutoil. ,,...
Breaking Medicine News(10 mins):Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), the glo...ounced that it will present key scientific data on...D) treatments lisdexamfetamine dimesylate (CII) an...CA. , , "Shire is committed to the advancement of...
... officials discuss strategy for a vaccine , ...ing sign that the swine flu outbreak has yet to ru...ew York City public schools were closed Thursday a...w York Mayor Michael Bloomberg said four students ...
... Boston Scientific Corporation (NYSE: BSX ) tod...and news announcements at the annual EuroPCR Scien...celona, Spain. , , "We are pleased to be announci...actical applications of the SYNTAX Score(TM)," sai...
... Quest Diagnostics Incorporated (NYSE: DGX ) an...ir physicians to share diagnostic laboratory test ...ection will enable physicians who use Quest Diagno...ant format into the patient,s protected account. P...
...5 Palatin Technologies, Inc. (NYSE Amex: PTN ) ...d March 31, 2009. Palatin reported net income of ..., for the quarter ended March 31, 2009, compared t...ere $5.2 million, compared to $0.7 million for the...
...as been known that aspirin is beneficial to patien... But which of the many different types of aspirin ...ers led by Dr. Sean Nordt from the University of C... chewed and swallowed, and chewable aspirin chewed...
Other Medicine News:Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 2Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 3Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 4Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 5Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 6Health News:Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18 7Health News:Swine Flu Closes 3 Schools in NYC 2Health News:Swine Flu Closes 3 Schools in NYC 3Health News:Swine Flu Closes 3 Schools in NYC 4Health News:Swine Flu Closes 3 Schools in NYC 5Health News:Swine Flu Closes 3 Schools in NYC 6Health News:Swine Flu Closes 3 Schools in NYC 7Health News:Swine Flu Closes 3 Schools in NYC 8Health News:Swine Flu Closes 3 Schools in NYC 9Health News:Swine Flu Closes 3 Schools in NYC 10Health News:Boston Scientific Announces Schedule for EuroPCR 2009 2Health News:Boston Scientific Announces Schedule for EuroPCR 2009 3Health News:Boston Scientific Announces Schedule for EuroPCR 2009 4Health News:Boston Scientific Announces Schedule for EuroPCR 2009 5Health News:Boston Scientific Announces Schedule for EuroPCR 2009 6Health News:Quest Diagnostics to Connect to Microsoft HealthVault and Empower Patients and Physicians to Share Diagnostic Laboratory Test Results Online 2Health News:Quest Diagnostics to Connect to Microsoft HealthVault and Empower Patients and Physicians to Share Diagnostic Laboratory Test Results Online 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 5Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 6
(Date:11/23/2009)...wswire-FirstCall/--Amgen(Nasdaq: AMGN )washonoredw...eandforBestNewDrugforNplate®(romiplostim),ata...neawardwaspresentedtoAmgenbyScripinrecognitionofth...y,spipeline,aswellasitsmixofcandidatesacrossdevelo...notableforitsfocusonunmetclinicalneed. ,, "Wear...
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...agnosticImagingMarketto2015 ,, http://www.re...ic-Imaging-Market-to-2015.html#utm_source=prnewswi... ,, Description ,, TheFutureoftheDiagnos...lMarketsDirect,s"TheFutureoftheDiagnosticImagingMa...
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...SandEMR ,, http://www.reportlinker.com/p0164...ewswire&utm_medium=pr&utm_campaign=prnewsw...most$1.3billion,representinganincreaseof6.7%over20...ediumhospitals(201-499beds),communityhospitals(200...
Breaking Medicine Technology:Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Kent State receives 242 7 million NSF training grant for environmental aquatic resource sensing 10643 1Kent State receives 242 7 million NSF training grant for environmental aquatic resource sensing 10643 2Doctors Point Out Gaps in U S Health Care 60776 1Doctors Point Out Gaps in U S Health Care 60776 2Practical Nursing Still a Growth Area in BC 60772 1Practical Nursing Still a Growth Area in BC 60772 2
...nced Cancer Patients, ROCKVILLE, Md., Dec. 4 Ent...rmaceutical company developing,therapeutics for th...oday,announced that it has commenced a multi-cente...th advanced pancreatic cancer. The primary objecti...or activity of,orally-administered MKC-1 in unrese...
...aluated Infrequent Dosing of Ustekinumab ...Pa. and BEERSE, Belgium, Dec. 4 Centocor, Inc.,an...hat regulatory,applications have been submitted re...n the United States and Europe for the treatment o...laque psoriasis. Centocor has,submitted a Biologic...
Other Medicine Technology:EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 2EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 3EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 4Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis 2Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis 3
Portex® Trach-Talk™ Blue Line® Tracheostomy Tubes
Portex Blue Line® Cuffed Fenestrated Tracheostomy Tubes
Portex Blue Line® Cuffed Tracheostomy Tubes
Bivona® TTS™ Tracheostomy Tubes
Medicine Products: